Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease.

•Anticholinergics effectively manage PD motor symptoms, but anticholinergics are associated with dementia risk.•Greater exposure to anticholinergics increases dementia risk in patients with early-stage PD.•For PD, anticholinergics should be prescribed cautiously.